{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T20:16:49Z","timestamp":1771791409471,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-449","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T13:40:21Z","timestamp":1405345221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 \u2013 1965"],"prefix":"10.1186","volume":"7","author":[{"given":"Emily J","family":"Cartwright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Rimland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,14]]},"reference":[{"issue":"No. RR-19","key":"2974_CR1","first-page":"1","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998, 47 (No. RR-19): 1-39.","journal-title":"MMWR"},{"issue":"RR-4","key":"2974_CR2","first-page":"1","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","unstructured":"Centers for Disease Control and Prevention: Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissue, and semen for evidence of hepatitis B and hepatitis C. MMWR. 1991, 40 (RR-4): 1-17.","journal-title":"MMWR"},{"key":"2974_CR3","unstructured":"Hepatitis C testing and prevention counseling guidelines for VA health care practitioners. http:\/\/www.hepatitis.va.gov\/ ,"},{"issue":"RR-4","key":"2974_CR4","first-page":"1","volume":"61","author":"BD Smith","year":"2012","unstructured":"Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW: Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965. MMWR Recomm Rep. 2012, 61 (RR-4): 1-32.","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"2974_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-2893.2010.01327.x","volume":"18","author":"WN Southern","year":"2011","unstructured":"Southern WN, Drainoni ML, Smith BD, Christiansen CL, McKee D, Gifford AL, Weinbaum CM, Thompson D, Koppelman E, Maher S, Litwin AH: Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. J Viral Hepat. 2011, 18 (7): 474-481.","journal-title":"J Viral Hepat"},{"issue":"2","key":"2974_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7326\/0003-4819-158-2-201301150-00574","volume":"158","author":"R Chou","year":"2013","unstructured":"Chou R, Cottrell EB, Wasson N, Rahman B, Guise JM: Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013, 158 (2): 101-108.","journal-title":"Ann Intern Med"},{"issue":"16","key":"2974_CR7","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jamainternmed.2013.8133","volume":"173","author":"LI Backus","year":"2013","unstructured":"Backus LI, Belperio PS, Loomis TP, Yip GH, Mole LA: Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care. JAMA Intern Med. 2013, 173 (16): 1549-1552.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2974_CR8","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1111\/j.1365-2893.2011.01539.x","volume":"19","author":"CV Almario","year":"2012","unstructured":"Almario CV, Vega M, Trooskin SB, Navarro VJ: Examining hepatitis C virus testing practices in primary care clinics. J Viral Hepat. 2012, 19 (2): e163-e169.","journal-title":"J Viral Hepat"},{"issue":"4","key":"2974_CR9","first-page":"250","volume":"10","author":"D Shatin","year":"2004","unstructured":"Shatin D, Schech SD, Patel K, McHutchison JG: Population-based hepatitis C surveillance and treatment in a national managed care organization. Am J Manag Care. 2004, 10 (4): 250-256.","journal-title":"Am J Manag Care"},{"issue":"6","key":"2974_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.dld.2011.12.014","volume":"44","author":"AH Litwin","year":"2012","unstructured":"Litwin AH, Smith BD, Drainoni ML, McKee D, Gifford AL, Koppelman E, Christiansen CL, Weinbaum CM, Southern WN: Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk. Dig Liver Dis. 2012, 44 (6): 497-503.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"2974_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1053\/jhep.2001.29303","volume":"34","author":"ME Briggs","year":"2001","unstructured":"Briggs ME, Baker C, Hall R, Gaziano JM, Gagnon D, Bzowej N, Wright TL: Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology. 2001, 34 (6): 1200-1205.","journal-title":"Hepatology"},{"issue":"8","key":"2974_CR12","first-page":"2071","volume":"97","author":"N Brau","year":"2002","unstructured":"Brau N, Bini EJ, Shahidi A, Aytaman A, Xiao P, Stancic S, Eng R, Brown ST, Paronetto F: Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area. Am J Gastroenterol. 2002, 97 (8): 2071-2078.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2974_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00004836-200403000-00016","volume":"38","author":"KL Sloan","year":"2004","unstructured":"Sloan KL, Straits-Troster KA, Dominitz JA, Kivlahan DR: Hepatitis C tested prevalence and comorbidities among veterans in the US Northwest. J Clin Gastroenterol. 2004, 38 (3): 279-284.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"2974_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1572-0241.2000.01854.x","volume":"95","author":"RC Cheung","year":"2000","unstructured":"Cheung RC: Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000, 95 (3): 740-747.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"2974_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006, 144 (10): 705-714.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2974_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1001\/archinte.167.2.166","volume":"167","author":"GL Armstrong","year":"2007","unstructured":"Armstrong GL: Injection drug users in the United States, 1979\u20132002: an aging population. Arch Intern Med. 2007, 167 (2): 166-173.","journal-title":"Arch Intern Med"},{"issue":"4","key":"2974_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1086\/654882","volume":"202","author":"EL Murphy","year":"2010","unstructured":"Murphy EL, Fang J, Tu Y, Cable R, Hillyer CD, Sacher R, Triulzi D, Gottschall JL, Busch MP: Hepatitis C virus prevalence and clearance among US blood donors, 2006\u20132007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis. 2010, 202 (4): 576-584.","journal-title":"J Infect Dis"},{"issue":"1","key":"2974_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0950268813000617","volume":"142","author":"SA McDonald","year":"2014","unstructured":"McDonald SA, Hutchinson SJ, Schnier C, McLeod A, Goldberg DJ: Estimating the number of injecting drug users in Scotland's HCV diagnosed population using capture-recapture methods. Epidemiol Infect. 2014, 142 (1): 200-207.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"2974_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/jinf.2002.1059","volume":"45","author":"MA Balogun","year":"2002","unstructured":"Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay NJ, Morgan-Capner P: The prevalence of hepatitis C in England and Wales. J Infect. 2002, 45 (4): 219-226.","journal-title":"J Infect"},{"issue":"2","key":"2974_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jmv.20343","volume":"76","author":"E Nerrienet","year":"2005","unstructured":"Nerrienet E, Pouillot R, Lachenal G, Njouom R, Mfoupouendoun J, Bilong C, Mauclere P, Pasquier C, Ayouba A: Hepatitis C virus infection in cameroon: a cohort-effect. J Med Virol. 2005, 76 (2): 208-214.","journal-title":"J Med Virol"},{"issue":"8","key":"2974_CR21","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1086\/605947","volume":"200","author":"K Page","year":"2009","unstructured":"Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP: Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009, 200 (8): 1216-1226.","journal-title":"J Infect Dis"},{"issue":"10","key":"2974_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1086\/522608","volume":"196","author":"CC Wang","year":"2007","unstructured":"Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR: Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis. 2007, 196 (10): 1474-1482.","journal-title":"J Infect Dis"},{"issue":"11","key":"2974_CR23","doi-asserted-by":"publisher","first-page":"e27555","DOI":"10.1371\/journal.pone.0027555","volume":"6","author":"CH van der Berg","year":"2011","unstructured":"van der Berg CH, Grady BP, Schinkel J, van de Laar T, Molenkamp R, van Houdt R, Coutinho RA, van Baarle D, Prins M: Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. Plos One. 2011, 6 (11): e27555-","journal-title":"Plos One"},{"key":"2974_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.26639","volume":"59","author":"J Grebely","year":"2014","unstructured":"Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M: The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014, 59: 109-120.","journal-title":"Hepatology"},{"key":"2974_CR25","unstructured":"Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005\u20132011. MMWR Morb Mortal Wkly Rep. 2013, 62 (18): 357-361."},{"issue":"18","key":"2974_CR26","first-page":"357","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention: Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR. 2013, 62 (18): 357-361.","journal-title":"MMWR"},{"issue":"20","key":"2974_CR27","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1056\/NEJMra1213651","volume":"368","author":"TJ Liang","year":"2013","unstructured":"Liang TJ, Ghany MG: Current and future therapies for hepatitis C virus infection. N Engl J Med. 2013, 368 (20): 1907-1917.","journal-title":"N Engl J Med"},{"issue":"10","key":"2974_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","volume":"147","author":"BJ Veldt","year":"2007","unstructured":"Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL: Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med. 2007, 147 (10): 677-684.","journal-title":"Ann Intern Med"},{"issue":"5","key":"2974_CR29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2009.12.028","volume":"52","author":"AC Cardoso","year":"2010","unstructured":"Cardoso AC, Moucari R, Figueiredo-Mendes C, Ripault MP, Giuily N, Castelnau C, Boyer N, Asselah T, Martinot-Peignoux M, Maylin S, Carvalho-Filho RJ, Valla D, Bedossa P, Marcellin P: Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis. J Hepatol. 2010, 52 (5): 652-657.","journal-title":"J Hepatol"},{"issue":"24","key":"2974_CR30","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","volume":"308","author":"AJ van der Meer","year":"2012","unstructured":"van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Duarte-Rojo A, Heathcote EJ, Manns MP, Kuske L, Zeuzem S, Hofmann WP, de Knegt RJ, Hansen BE, Janssen HL: Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012, 308 (24): 2584-2593.","journal-title":"JAMA"},{"issue":"3","key":"2974_CR31","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.23744","volume":"52","author":"TR Morgan","year":"2010","unstructured":"Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, De Santo JL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Dienstag JL, Morishima C, Lindsay KL, Lok AS: Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology. 2010, 52 (3): 833-844.","journal-title":"Hepatology"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T15:47:57Z","timestamp":1565624877000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,14]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2974"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-449","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,14]]},"assertion":[{"value":"23 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"449"}}